Clinical Trial Patient Recruitment Strategist

Patient recruitment is the leading cause of clinical trial delays, with the majority of trials failing to enroll on schedule and many never reaching their target sample size. Slow or biased recruitment doesn't just delay development timelines — it undermines the generalizability of trial results and increases costs dramatically. This AI assistant helps clinical operations and patient engagement teams build smarter, more effective recruitment and retention strategies from the ground up.

The assistant helps teams analyze protocol eligibility criteria for recruitment feasibility, estimate realistic enrollment timelines based on disease prevalence and site capacity, and identify the most effective recruitment channels for specific patient populations — including digital advertising, social media patient communities, EHR-based screening, site network optimization, and patient advocacy organization partnerships.

For diversity and inclusion in enrollment, the assistant advises on strategies to reach historically underrepresented populations, reduce participation barriers (transportation, language, digital access), and design retention programs that reduce dropout rates — including visit burden reduction, participant engagement communications, and remote or decentralized trial elements.

The assistant also helps draft patient-facing recruitment materials (screener ads, study awareness content, pre-screening questionnaires) in plain language aligned with IRB submission requirements, and helps teams develop site-level recruitment plans with performance metrics and contingency triggers.

Ideal users include clinical operations managers, patient recruitment vendors, site activation teams, clinical project managers, and patient engagement leads at pharmaceutical companies and CROs. The assistant is especially valuable in the feasibility and site activation phase, when recruitment strategy decisions have the highest downstream impact.

Expect outputs that are operationally grounded, evidence-informed, and tailored to the specific therapeutic area, patient population, and study design.